Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
94.71
+1.36 (+1.46%)
Official Closing Price
Updated: 4:01 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion.
Via
Benzinga
Topics
Government
Exposures
Political
MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 17, 2025
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MRK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 17, 2025
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Decoding Merck & Co's Options Activity: What's the Big Picture?
February 13, 2025
Via
Benzinga
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
February 15, 2025
From
The Schall Law Firm
Via
Business Wire
MarketBeat Week in Review – 02/10 - 02/14
February 15, 2025
Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in
Via
MarketBeat
Topics
Credit Cards
Economy
Government
Exposures
Interest Rates
Political
Tariff
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
Via
Benzinga
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock
February 11, 2025
Via
Benzinga
Market Whales and Their Recent Bets on MRK Options
February 06, 2025
Via
Benzinga
Top 3 Health Care Stocks You'll Regret Missing This Month
February 06, 2025
Via
Benzinga
Why Merck Stock Is Plummeting Today
February 04, 2025
Via
The Motley Fool
In a market where value is scarce, NYSE:MRK offers a refreshing opportunity with its solid fundamentals.
February 14, 2025
MERCK & CO. INC. has caught the attention as a great value stock. NYSE:MRK excels in profitability, solvency, and liquidity, all while being very reasonably priced.
Via
Chartmill
MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 14, 2025
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Rosen Law Firm Urges Merck & Co., Inc. (NYSE: MRK) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
February 13, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Benzinga
Topics
Government
Exposures
Political
3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
February 13, 2025
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
February 13, 2025
Via
The Motley Fool
Rosen Law Firm Encourages Merck & Co. Inc. Investors to Inquire About Securities Class Action Investigation – MRK
February 12, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes
February 12, 2025
This payment represents the second milestone in the collaboration between Neuphoria and Merck, with Neuphoria potentially eligible for up to $450 million in additional milestone payments.
Via
Stocktwits
Gilead Sciences Beats Q4 EPS Forecast
February 11, 2025
Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.
Via
The Motley Fool
Merck Stock Heads For 5th Day Of Losses As TD Cowen Downgrades On Gardasil Woes, But Retail Holds Strong
February 10, 2025
The HPV vaccine had been a key growth driver in China until last year when economic headwinds disrupted demand.
Via
Stocktwits
Merck: 4 No-Brainer Reasons to Buy This Dip
February 10, 2025
Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity.
Via
MarketBeat
Better High-Yield Dividend Stock: Pfizer vs. Merck
February 10, 2025
Via
The Motley Fool
Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
February 06, 2025
From
Merck & Co., Inc.
Via
Business Wire
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
February 05, 2025
Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a lower-than-expected 2025 outlook.
Via
Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
February 04, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
Merck (MRK) Q4 2024 Earnings Call Transcript
February 04, 2025
MRK earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Looking for the most active stocks in the S&P500 index on Tuesday?
February 04, 2025
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for...
Via
Chartmill
Merck Retail Traders See Buying Opportunity As Stock Dives Toward Worst Day in 17 Years On Weak Guidance
February 04, 2025
Gardasil, its HPV vaccine, posted a 17% decline in sales to $1.55 billion, primarily due to lower demand in China.
Via
Stocktwits
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
February 04, 2025
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Tuesday. Stay informed about the market activity below.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.